CMS Issues Final Rule on Changes to the Medicare Advantage and Part D Programs
Client Alert | 1 min read | 04.07.10
On April 6, 2010, CMS issued a final rule that revises regulations governing the Medicare Advantage program and the Part D prescription drug benefit program. The proposed rule was issued on October 22, 2009. Click here for our summary on Crowell.com.
According to CMS, the final rule strengthens beneficiary protections, ensures that plan offerings to beneficiaries include meaningful differences, improves plan payment rules and processes, strengthens various program participation and exit requirements, improve data collection for oversight and quality assessment, implement a new Part D formulary policy, and clarify or add other important program requirements. The final rule also includes a dispute and appeals process for risk-adjustment data validation.
The final rule will be published in the Federal Register on April 15, 2010, but is available now at http://www.federalregister.gov/inspection.aspx#special
Insights
Client Alert | 11 min read | 12.15.25
New York LLC Transparency Act: Key Requirements and Deadlines
On January 1, 2026 (“Effective Date”), the New York LLC Transparency Act ("New York Act”) is scheduled to take effect, introducing new disclosure requirements for limited liability companies (“LLCs”) formed or registered to do business in New York State. The New York Act is expected to impose the type of broad beneficial ownership requirements the federal CTA and rules implementing it was designed to require, before the federal government’s decision to limit the scope of the CTA’s beneficial ownership reporting requirements to foreign companies and foreign beneficial owners.
Client Alert | 7 min read | 12.15.25
The New EU “Pharma Package:” EU Reaches Landmark Deal on Pharma Package
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality
Client Alert | 8 min read | 12.11.25
Director Squires Revamps the Workings of the U.S. Patent Office
